A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations

Yamaura, T., Nakatani, T., Uda, K., Ogura, H., Shin, W., Kurokawa, N., Saito, K., Fujikawa, N., Date, T., Takasaki, M., Terada, D., Hirai, A., Akashi, A., Chen, F., Adachi, Y., Ishikawa, Y., Hayakawa, F., Hagiwara, S., Naoe, T., Kiyoi, H.
American Society of Hematology (ASH)
Published 2018